Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 3 studies | 27% ± 6% |
Insufficient scRNA-seq data for expression of RIN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 3063.22 | 1809 / 1809 | 96% | 11.44 | 454 / 472 |
uterus | 99% | 741.42 | 169 / 170 | 95% | 16.45 | 437 / 459 |
stomach | 96% | 710.63 | 343 / 359 | 97% | 14.40 | 276 / 286 |
lung | 96% | 739.23 | 556 / 578 | 89% | 9.28 | 1032 / 1155 |
breast | 96% | 651.69 | 441 / 459 | 88% | 5.23 | 979 / 1118 |
esophagus | 84% | 1150.88 | 1211 / 1445 | 99% | 15.85 | 181 / 183 |
intestine | 84% | 535.28 | 808 / 966 | 99% | 15.23 | 520 / 527 |
bladder | 86% | 737.00 | 18 / 21 | 96% | 12.55 | 482 / 504 |
ovary | 92% | 493.18 | 166 / 180 | 84% | 5.04 | 360 / 430 |
adrenal gland | 91% | 555.39 | 235 / 258 | 84% | 13.00 | 194 / 230 |
pancreas | 76% | 357.08 | 248 / 328 | 97% | 13.92 | 173 / 178 |
prostate | 97% | 1088.53 | 237 / 245 | 69% | 2.81 | 348 / 502 |
brain | 87% | 1505.86 | 2286 / 2642 | 71% | 5.83 | 499 / 705 |
thymus | 70% | 318.03 | 459 / 653 | 82% | 5.16 | 496 / 605 |
kidney | 66% | 381.19 | 59 / 89 | 82% | 6.06 | 739 / 901 |
eye | 0% | 0 | 0 / 0 | 100% | 7.91 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.42 | 1 / 1 |
spleen | 100% | 896.70 | 240 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 18.98 | 44 / 45 |
adipose | 95% | 668.49 | 1147 / 1204 | 0% | 0 | 0 / 0 |
muscle | 66% | 504.20 | 533 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 66% | 319.62 | 885 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 55% | 327.77 | 514 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 1.28 | 12 / 29 |
heart | 41% | 187.36 | 353 / 861 | 0% | 0 | 0 / 0 |
liver | 7% | 32.28 | 15 / 226 | 30% | 1.74 | 120 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0006897 | Biological process | endocytosis |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0030139 | Cellular component | endocytic vesicle |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | RIN1 |
Protein name | Ras and Rab interactor 1 isoform 2 Ras and Rab interactor 1 (Ras inhibitor JC99) (Ras interaction/interference protein 1) Ras and Rab interactor 1 isoform 3 Ras and Rab interactor 1 |
Synonyms | hCG_20306 |
Description | FUNCTION: Ras effector protein, which may serve as an inhibitory modulator of neuronal plasticity in aversive memory formation. Can affect Ras signaling at different levels. First, by competing with RAF1 protein for binding to activated Ras. Second, by enhancing signaling from ABL1 and ABL2, which regulate cytoskeletal remodeling. Third, by activating RAB5A, possibly by functioning as a guanine nucleotide exchange factor (GEF) for RAB5A, by exchanging bound GDP for free GTP, and facilitating Ras-activated receptor endocytosis. . |
Accessions | ENST00000530745.3 H0YCG8 ENST00000534824.5 ENST00000530056.1 E9PNR2 A0A0S2Z4T3 ENST00000627248.1 A0A0S2Z4T5 ENST00000311320.9 [Q13671-1] A0A0S2Z4U0 Q13671 E9PMB8 |